randomized controlled trial
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Adult patients aged more than 65 years with a physical status of 1-3(the American Society of Anesthesiologists rating) who are scheduled to undergo GI cancer surgery
Exclusion criteria
Exclusion criteria: Patients with a history of hypersensitivity to drugs, and those receiving analgesics, sedatives or psychiatric medication will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the difference of intravenous IV remifentanil dose | — |
Secondary
| Measure | Time frame |
|---|---|
| peri operative cortisol, epinephrine, norepinephrine, ACTH,IL6, TNF a, NK cell activity | — |
Countries
Asia(except Japan)
Contacts
Guro Hospital, Korea University College of Medicine Department of Anesthesiology and Pain Medicine